Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder

There is increasing interest in the use of cannabis and its major non-intoxicating component cannabidiol (CBD) as a treatment for mental health and neurodevelopmental disorders, such as autism spectrum disorder (ASD). However, before launching large-scale clinical trials, a better understanding of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pretzsch, Charlotte Marie, Freyberg, Jan, Voinescu, Bogdan, Lythgoe, David, Horder, Jamie, Mendez, Maria Andreina, Wichers, Robert, Ajram, Laura, Ivin, Glynis, Heasman, Martin, Edden, Richard A. E., Williams, Steven, Murphy, Declan G. M., Daly, Eileen, McAlonan, Gráinne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784992/
https://www.ncbi.nlm.nih.gov/pubmed/30758329
http://dx.doi.org/10.1038/s41386-019-0333-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784992/
https://www.ncbi.nlm.nih.gov/pubmed/30758329
http://dx.doi.org/10.1038/s41386-019-0333-8

Ejemplares similares